Abstract

Copper(II) complexes of ferrocene(Fc)-conjugated reduced Schiff base of l-tyrosine (Fc-TyrH), viz., [Cu(Fc-Tyr)(L)](ClO4), where L is 1,10-phenanthroline (phen, 1), dipyrido[3,2-d:2′,3′-f]quinoxaline (dpq, 2), dipyrido[3,2-a:2′,3′-c]phenazine (dppz, 3) and 2-(naphthalen-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline (nip, 4), were prepared and tested for their photocytotoxicity in cancer cells. [Cu(Fc-Phe)(phen)](ClO4) (5) of l-phenylalanine and [Cu(Ph-Tyr)(L)(ClO4)] of the reduced Schiff base Ph-TyrH derived from benzaldehyde and l-tyrosine having phen (6) and dppz (7), and [Cu(Ph-Phe)(phen)(ClO4)] (8) using l-phenylalanine were prepared and used as controls. Complexes 5 and 6 were structurally characterized by X-ray crystallography. A copper(II)-based d–d band near 600nm and a ferrocenyl band at ∼450nm were observed in DMF–Tris–HCl buffer (1:4v/v) in respective complexes. The complexes are photocleavers of pUC19 DNA in visible light forming •OH radicals. They are cytotoxic in HeLa (human cervical cancer) and MCF-7 (human breast cancer) cells showing an enhancement of cytotoxicity in visible light. Fluorescence imaging shows nuclear localization of the complexes.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.